Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Büşra Tanyıldızı Küçük has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of inflammatory markers (Inflammatory Burden Index, Systemic Inflammation Response Index, Systemic Immune-Inflammation Index) and modified Glasgow Prognostic Score with 30- and 90-day mortality in a level 3 surgical intensive care unit

    by Veysel Garani Soylu, Ayşe Yılmaz, Öztürk Taşkın, Ufuk Demir, Büşra Tanyıldızı Küçük, Ayşegül Doğan, Hamdican Erdoğan, Zahide Doğanay, Funda Çatan İnAn

    Aims: We aimed to examine the relationship between systemic inflammatory markers and mGPS with 30- and 90-day mortality in critically ill patients who underwent various types of surgery (abdominal, neurosurgical, orthopedic, and urogynecological surgeries) and were followed up in a tertiary surgical intensive care unit. Methods: This retrospective study included patients who were postoperatively followed in the tertiary surgical intensive care unit between January 2021-2025. A total of 455 patients were included in the study. Data regarding patients’ age, comorbidities, length of hospital stay, length of intensive care unit stay, preoperative 24-hour inflammatory parameters (leukocyte, neutrophil, platelet, lymphocyte, monocyte, CRP, albumin, procalcitonin), and APACHE II and SAPS II scores at intensive care unit admission were collected. Composite inflammatory biomarkers (IBI, SIRI, SII, mGPS) were calculated using formulas. Results: A total of 455 postoperative patients were included in the study. Among them, 270 (59.3%) were male, and the mean age was 69.69?±?17.18 years. Of all patients, 193 (42.2%) underwent abdominal surgery, 74 (16.3%) underwent neurosurgery, 140(30.8%) underwent orthopedic surgery, and 48 (10.5%) underwent urogynecological surgery. Among the inflammatory indices, the Inflammatory Burden Index (p = 0.001 for 30-day, p < 0.001 for 90-day), Neutrophil-to-Lymphocyte Ratio(p = 0.029 for 30-day, p = 0.033 for 90-day), and Modified Glasgow Prognostic Score (p = 0.005 for 30-day, p < 0.001 for 90-day) were significant predictors of both short- and mid-term mortality. Conclusion: Among postoperative surgical patients, Inflammatory Burden Index and Modified Glasgow Prognostic Score are significant predictors of 30/90 day mortality.

  • Open Access

    Predictive Value of the CRP/Albumin Ratio in Mortality Prediction in Hip Fracture Surgery Patients Admitted to Intensive Care

    by Ayşe Yılmaz, Veysel Garani Soylu, Öztürk Taşkın, Ufuk Demir, Büşra Tanyıldızı Küçük, Özgür Yılmaz, Azra Aytaç, Zahide Doğanay

    Background: Hip fracture surgery patients admitted to the intensive care unit (ICU) have high postoperative mortality, and early risk stratification remains challenging. This study aimed to evaluate the predictive value of the C-reactive protein/albumin ratio (CAR) for 30-day and 90-day mortality in hip fracture surgery patients admitted to the ICU. Methods: This retrospective cohort study included 134 adult patients who underwent surgery for hip fracture and were admitted to the ICU between June 2021 and June 2023. Demographic characteristics, comorbidities, APACHE II and SAPS II scores, and laboratory parameters measured within the first 24 h of ICU admission were recorded. CAR was calculated by dividing CRP (mg/L) by albumin (g/dL). The primary outcomes were 30-day and 90-day mortality. Cox proportional hazards regression analysis was performed to identify independent predictors of mortality, and receiver operating characteristic (ROC) curve analysis was used to assess the discriminative ability of CAR. Results: The 30-day and 90-day mortality rates were 10.4% and 22.4%, respectively. CAR and serum albumin levels were significantly associated with both 30-day and 90-day mortality (p < 0.01), whereas CRP alone was not. In ROC analysis, CAR demonstrated excellent predictive performance for 30-day mortality (AUC: 0.991; 95% CI: 0.975–1.000; cutoff: 38.46; sensitivity: 92.9%; specificity: 92.5%) and good performance for 90-day mortality (AUC: 0.847; 95% CI: 0.776–0.918; cutoff: 25.43). Cox regression analysis identified CAR as an independent predictor of both 30-day (Exp(B) = 1.048, p < 0.001) and 90-day mortality (Exp(B) = 1.025, p = 0.002). Conclusions: The CRP/albumin ratio is a strong and independent predictor of short- and mid-term mortality in hip fracture surgery patients admitted to the ICU. Due to its simplicity and rapid availability, CAR may serve as a practical adjunctive biomarker for early risk stratification in this high-risk population.

  • Pediatric fatal aluminum phosphide poisoning: A case report with management strategies

    by Eren Yildiz, Emrah Cigri, Gizem Kurada, Busra Tanyildizi Kucuk, Aysegul Dogan, Hasim Yasin Ersahin, Ayse Yilmaz

    Aluminum phosphide (AlP) is a highly lethal pesticide that releases phosphine gas upon contact with moisture, leading to marked impairment of mitochondrial function, severe oxidative stress, and multiorgan failure. A fifteen-year-old male patient was brought to the emergency department due to loss of consciousness following accidental ingestion of a tablet containing AlP. Severe metabolic acidosis and refractory cardiogenic shock developed within a short time; despite intensive fluid resuscitation, high-dose vasopressor support, and comprehensive treatment approaches including mechanical ventilation, hemodynamic stability could not be achieved, and the patient died due to progressive circulatory failure. The absence of a specific antidote makes the treatment of AlP poisoning extremely challenging and significantly limits management options, particularly in severe cases. In the literature, the pathophysiological mechanisms of phosphine toxicity have been described in detail, and vasopressor therapies in shock management, antioxidant approaches aimed at reducing oxidative injury, and extracorporeal membrane oxygenation (ECMO) as a potential rescue treatment option in refractory cardiogenic shock come to the forefront. This case is presented to highlight the clinical features and management challenges of fatal AlP poisoning.

  • Suprainguinal Fascia Iliaca Block for Surgical Anesthesia in Endovenous Radiofrequency Ablation

    by Ufuk Demir, Öztürk Taşkın, Üzeyir Yılmaz, Ayşe Yılmaz, Büşra Tanyıldızı Küçük

  • Open Access

    Is the serum creatinine/alanine transaminase ratio a predictor of mortality in elderly patients with acute ischemic stroke?

    by Özgür Yılmaz, Ayşe Yılmaz, Veysel Garani Soylu, Öztürk Taşkın, Ufuk Demir, Gizem Kurada, Büşra Tanyıldızı Küçük, Zahide Doğanay

    Aims: In recent years, the rate of admission to intensive care in the elderly population has been increasing. We aimed to investigate the relationship between the serum creatinine/alanine transaminase ratio (sCr/ALT), which is thought to be a simpler method for predicting mortality in the elderly patient group instead of intensive care scoring systems that are difficult to calculate, and mortality. Methods: Medical records of patients treated in the intensive care unit due to acute ischemic stroke between January 2017 and October 2021 were evaluated. The study included 189 patients over the age of 85 who were diagnosed with cerebrovascular disease, had no known liver or kidney disease, and had a creatinine value of <1.5 mg/dl. APACHE II, SAPS II, and NIHSS scores calculated during admission to the intensive care unit were calculated from system data and patient records. Demographic data, additional diseases, hospital stay, laboratory values, sCr/ALT ratios and 28-day mortality status of the patients were recorded. Results: In a total of 189 patients, 66 male and 123 female, included in the study, mortality occurred at a rate of 65.1% (n: 123) in the first 28 days. The presence of coronary artery disease (p=0.044) was significantly higher in mortal cases. There were statistically significant differences in APACHE II score (p<0.001), SAPS II (p<0.001), AST (p=0.008), creatinine (p<0.001), sCr/ALT ratio (p<0.001), neutrophil/lymphocyte ratio (p=0.049), ferritin (p=0.003) and CRP (p=0.006) in mortal cases and non-mortals. In mortal cases, NIHSS severe (p<0.001) percentage was significantly higher than in other patients. ALT (p<0.001), lymphocyte (p=0.009) and albumin (p<0.001) values were statistically significantly lower in mortal cases than in non-mortals. When we evaluated the 28-day mortality prediction performances of the variables, the sCr/ALT ratio was found to have 85.4% sensitivity and 84.8% specificity, the albumin value had 85.4% sensitivity and 60.6% specificity, and the APACHE II score had 61.8% sensitivity and 90.9% specificity . Conclusion: NIHSS, APACHI II and SAPS II are used as mortality and disease severity indicators in elderly intensive care patients with acute ischemic stroke. When compared with these scores, the sCr/ALT value is a valuable indicator in predicting mortality. We found that the sCr/ALT ratio, which is easily worked on and calculated in many centers, can better predict mortality in elderly patients with ischemic stroke.

  • Concomitant Hidden Skull Base Defects in Patients with Sternberg Canal CSF Fistulas

    by Cem Meco, H. Basak, S. Beton, S. Mulazimoglu, B. Kucuk, I. Yorulmaz

    Objective: The aim of the study was to identify concomitant hidden skull base defects in patients with a persistent lateral craniopharyngeal canal (Stenberg canal CSF fistula). Study Design: Retrospective analysis. Methods: We reviewed patients who were operated for a Sternbergs canal CSF fistula from 2007 to 2014 at Ankara University. In addition to imaging, all patients received preoperative intrathecal 5% sodium fluorescein. Endonasal endoscopic approach was used for repair, nearby a bilateral diagnostic endoscopy with fluorescein filter, performed to search for concomitant defects. Results: A total of five Sternberg canal CSF fistula patients were operated. Other than primary defects at expected locations on sphenoid sinus lateral walls, we identified a second hidden skull base defect as a small meningocele without CSF leakage in two patients. Both defects were around olfactory fibers, one located at the contralateral anterior and other at the ipsilateral posterior cribriform plate according to the side of primary defects. In all patients, watertight closure of all CSF fistulas and all identified skull base defects were achieved and no recurrences were observed in a mean follow-up time of 32 months. Conclusion: In our caseload patients who were diagnosed for a Sternberg canal CSF fistula had a second skull base defect with a high percentage. Surgeons should be aware of this fact and repair these as well, to entirely protect patients from the risk of ascending meningitis.

  • Endonasal Endoscopic Management of Advanced Staged Juvenile Nasopharyngeal Angiofibromas

    by C. Meco, S. Beton, E. Ocak, H. Basak, I. Yorulmaz, B. Kucuk

    Objectives: To evaluate the results of endonasal endoscopic removal of advanced staged juvenile nasopharyngeal angiofibromas (JNA) with pterygopalatine fossa, cavernous sinus, and intracranial involvements; to discuss the limits of the endoscopic approach. Design: Retrospective case series analysis. Methods: From 2004 to 2011, 12 patients with JNA were treated with the endonasal endoscopic technique. Tumor stage, embolization, blood loss, intraoperative and postoperative complications, and residual or recurrent tumor rates were evaluated retrospectively. Results: In our series, 10 patients were over stage IIB on the Radkowski classification; most of the cases fully occupied the pterygopalatine fossa, and four cases had extensions into the cavernous sinus, infratemporal fossa, and middle cranial fossa. Total endonasal endoscopic removal was achieved in all patients. Embolization was done in all cases except one. Bleeding from cavernous sinus and pterygopalatine vessels was successfully managed in all cases. Median follow-up were 44 months, and no patients had residual or recurrent tumor evaluated by endoscopy and MRI scans. Conclusion: Our case series demonstrates that endoscopic techniques are the most efficient treatment modality for eradication of JNA, even in advanced stages with cavernous sinus and intracranial extension. Although various open approaches are also reported to be highly efficient, as shown in this study, the endoscopic approach yields less morbidity in benefit of JNA patients. In each case, the extent of cavernous sinus and intracranial involvement should, however, be carefully evaluated on radiological studies for assessment of total tumor removal, as well as full control of bleeding by endoscopic techniques.

  • Endoscopic Resection of Nasal Septal Chondrosarcoma with Skull Base Extension—Preliminary Results of a Case

    by Cem Meco, K. Boynukalin, M. Gökcan, F. Aydiner, T. Aktürk, S. Erekul, M. Gerceker, B. Kücük

    Introduction: Nasal septal chondrosarcoma is an infrequent disease with fewer than 50 cases described in the literature. Its optimal management depends on the local control of the tumor, as no neck or distant metastases are involved. Hence, its preferred treatment is radical surgical resection through various open approaches which assure good exposure and resection. On the other hand, advances in endoscopic sinus surgery technique and powered instrumentation enable otolaryngologists to achieve nearly the same results through the endonasal endoscopic approach for some various selected tumors of the nose and skull base. In the literature, successful endoscopic resection of three septal chondrosarcoma cases have been reported. However, none of them has shown extension to the skull base, ours being the first to be reported. Material and Method: The presented nasal septal chondrosarcoma case had tumor involvement at crista galli along the skull base. Preoperative biopsy indicated an initial diagnosis of nasal septal chondroma; thus, the endonasal endoscopic approach was selected for surgery. Surgical specimen determined the final diagnosis, after which the patient also had radiotherapy in addition to the surgery. We report the preliminary result of this case whose nasal septal chondrosarcoma with skull base extention was endoscopically resected. Until now, there has been no report of endoscopic resection of nasal septal chondrosarcoma with such an extension. Result: The tumor was totally removed with the help of angled endoscopes and powered instrumentation through an endonasal endoscopic approach. The neighboring dura along the skull base were also resected and dura repair was successfully achieved, confirmed by postoperative beta-2-transferrin testing. Up to now, the patient has had no evidence of recurrence or residual disease at the 8-month follow-up. However, there is a definitive need for much longer follow-up periods and more selected case material to evaluate the efficacy of this minimally invasive approach for this specific kind of tumor. Additionally, since 20% of head and neck chondrosarcomas may be initially misdiagnosed as chondromas, it is necessary to take adequate biopsy specimens to avoid the sampling errors as in our case. Conclusion: With the enforcement of this case we have demonstrated that endoscopic total resection of nasal septal chondrosarcomas is possible even with skull base extension. The endoscopic approach has the advantage of avoiding potential morbidity of open approaches that could be caused by skin incisions or disruption of the facial skeleton. Although we do not advocate the use of the endoscopic approach for all malignant tumors, in selected patients with the availability of special instrumentation it is feasible to choose this minimally invasive approach with promising results and reserve more aggressive open approaches for recurrence cases.